6MHPCDX-1140mBRAFpoly-ICLCCDX-1140-mediatedhigh-risk melanomamelanoma
…ssess safety and immunogenicity. Participants received vaccine (6MHP+mBRAF+poly-ICLC) with a dose-escalation allocation of CDX-1140 …
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CDX-1140 ×
CDX-1140
This drug is selected. Its supporting articles are shown below.